WP
DCPH

Woodline Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Woodline Partners’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-396,239
Closed -$6.39M – 661
2023
Q4 		$6.39M Buy
+396,239
New +$5.05M 0.07% 287
2023
Q2 		– Sell
-339,905
Closed -$5.25M – 790
2023
Q1 		$5.25M Buy
+339,905
New +$5.68M 0.07% 289
2021
Q1 		– Sell
-34,797
Closed -$1.99M – 485
2020
Q4 		$1.99M Buy
+34,797
New +$2.06M 0.05% 196
2020
Q1 		– Sell
-22,660
Closed -$1.41M – 179
2019
Q4 		$1.41M Buy
+22,660
New +$1.08M 0.06% 104

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Woodline Partners's DCPH Position: Q1 2024 in Review

Woodline Partners sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2024, closing a stake of 396,239 shares — an estimated $6.39M sold.

Woodline Partners first reported a position in DCPH in Q4 2019 and held it in 4 quarters. The position peaked at $6.39M in Q4 2023. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

  • Woodline Partners reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Woodline Partners sold 396,239 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $6.39M.
  • Woodline Partners first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • Woodline Partners's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $6.39M in Q4 2023.
  • 177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.